Is ELYM or DVY a better dividend investment in 2026?

ELYM currently yields 39.14% with a 5% 5-year dividend growth rate. DVY yields 3.50% with 5% growth. The better choice depends on your goal: ELYM offers higher current income.

What is the dividend yield difference between ELYM and DVY?

ELYM has a forward dividend yield of 39.14% ($2.00/share annually). DVY yields 3.50% ($5.25/share annually). The yield gap is 35.64 percentage points.

Home › Compare › ELYM vs DVY

ELYM vs DVY: Dividend Comparison 2026

ELYM yields 39.14% · DVY yields 3.50%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ELYM wins by $196.1K in total portfolio value

INVESTMENT

TIME HORIZON10 years

ELYM

● Live price

39.14%

Share price

$5.11

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$221.2K

Annual income

$36,710.06

Full ELYM calculator →

DVY

● Live price

3.50%

Share price

$150.03

Annual div

$5.25

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.1K

Annual income

$437.78

Full DVY calculator →

Portfolio growth — ELYM vs DVY

📍 ELYM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ELYM	DVY
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ELYM + DVY cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ELYM pays

DVY pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ELYM

Annual income on $10K today (after 15% tax)

$3,326.81/yr

After 10yr DRIP, annual income (after tax)

$31,203.55/yr

DVY

Annual income on $10K today (after 15% tax)

$297.17/yr

After 10yr DRIP, annual income (after tax)

$372.11/yr

At 15% tax rate, ELYM beats the other by $30,831.44/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ELYM + DVY for your $10,000?

ELYM: 50%DVY: 50%

100% DVY50/50100% ELYM

Portfolio after 10yr

$123.1K

Annual income

$18,573.92/yr

Blended yield

15.08%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ELYM right now

ELYM

Analyst Ratings

Buy

Hold

Consensus: Buy

Altman Z

25.2

Piotroski

2/9

DVY

No analyst data

Altman Z

307.5

Piotroski

1/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ELYM buys

DVY buys

No recent congressional trades found for ELYM or DVY in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricELYMDVY

Forward yield	39.14% ✓	3.50%
Annual dividend / share	$2.00	$5.25 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$221.2K ✓	$25.1K
Annual income after 10y	$36,710.06 ✓	$437.78
Total dividends collected	$165.4K ✓	$4.0K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: ELYM vs DVY ($10,000, DRIP)

Year	ELYM Portfolio	ELYM Income/yr	DVY Portfolio	DVY Income/yr	Gap
1← crossover	$14,614	$3,913.89	$11,050	$349.62	+$3.6K → ELYM
2	$20,982	$5,345.54	$12,184	$361.04	+$8.8K → ELYM
3	$29,624	$7,172.93	$13,409	$372.07	+$16.2K → ELYM
4	$41,162	$9,464.62	$14,730	$382.68	+$26.4K → ELYM
5	$56,334	$12,290.65	$16,154	$392.89	+$40.2K → ELYM
6	$75,998	$15,720.42	$17,688	$402.69	+$58.3K → ELYM
7	$101,138	$19,820.29	$19,338	$412.07	+$81.8K → ELYM
8	$132,869	$24,651.24	$21,113	$421.04	+$111.8K → ELYM
9	$172,437	$30,266.60	$23,020	$429.61	+$149.4K → ELYM
10	$221,217	$36,710.06	$25,070	$437.78	+$196.1K → ELYM

ELYM vs DVY: Complete Analysis 2026

ELYM — Stock

Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase IIa clinical trial; and ETX-155 for the treatment of major depressive disorder, perimenopausal depression, and focal onset seizures that is in Phase I clinical trial. The company also develops preclinical pipeline programs, such as Kv7 Program for pain, epilepsy, and depression; and Anxiolytic for the treatment of generalized anxiety disorder. Eliem Therapeutics, Inc. was incorporated in 2018 and is headquartered in Redmond, Washington.

Full ELYM Calculator →

DVY — ETF

The iShares Select Dividend ETF seeks to track the investment results of an index composed of relatively high dividend paying U.S. equities.

Full DVY Calculator →

📬

Get this ELYM vs DVY comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ELYM vs SCHD ELYM vs JEPI ELYM vs O ELYM vs KO ELYM vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.